Predictive Medicine. XIII. Tolerance Testing

1972 ◽  
Vol 20 (3) ◽  
pp. 121-126
Author(s):  
E. CHERASKIN ◽  
W. M. RINGSDORF
Keyword(s):  
Predictive Medicine ◽  
Tolerance Testing

Forecasting cancer: from precision to predictive medicine

Med ◽  
2021 ◽  
Vol 2 (9) ◽  
pp. 1004-1010
Author(s):  
Elana J. Fertig ◽  
Elizabeth M. Jaffee ◽  
Paul Macklin ◽  
Vered Stearns ◽  
Chenguang Wang
Keyword(s):  
Predictive Medicine

scholarly journals Validation of biomarkers of diabetic retinopathy for preventing and predictive medicine in diabetic complications

2014 ◽  
Vol 5 (S1) ◽  
Author(s):  
Folami Lamoke ◽  
Sean Shaw ◽  
Babak Baban ◽  
Anna Lisa Montemari ◽  
Francesco Facchiano ◽  
...  
Keyword(s):  
Diabetic Retinopathy ◽  
Diabetic Complications ◽  
Predictive Medicine

Does Exercise Tolerance Testing at 60 Days Poststroke Predict Rehabilitation Performance?

2013 ◽  
Vol 94 (7) ◽  
pp. 1223-1229 ◽  
Author(s):  
Dorian K. Rose ◽  
Andrea L. Behrman ◽  
Stephen E. Nadeau ◽  
Anatole D. Martin ◽  
Richard S. Schofield ◽  
...  
Keyword(s):  
Exercise Tolerance ◽  
Exercise Tolerance Testing ◽  
Tolerance Testing

Informative combination of CLU rs11136000, serum HDL levels, diabetes, and age as a new piece of puzzle-picture of predictive medicine for cognitive disorders

2018 ◽  
Vol 46 (1) ◽  
pp. 1033-1041 ◽  
Author(s):  
Mohsen Aghajanpour-Mir ◽  
Fatemeh Amjadi-Moheb ◽  
Tahereh Dadkhah ◽  
Seyed Reza Hosseini ◽  
Elham Ghadami ◽  
...  
Keyword(s):  
Cognitive Disorders ◽  
Predictive Medicine

scholarly journals SELDI ProteinChip®Array Technology: Protein-Based Predictive Medicine and Drug Discovery Applications

2003 ◽  
Vol 2003 (4) ◽  
pp. 237-241 ◽  
Author(s):  
Guru Reddy ◽  
Enrique A. Dalmasso
Keyword(s):  
Drug Discovery ◽  
Drug Targets ◽  
Treatment Options ◽  
Drug Effects ◽  
Proteome Analysis ◽  
Predictive Medicine ◽  
Protein Drug ◽  
Proteinchip Array ◽  
Drug Candidates ◽  
Array Technology

Predictive medicine, utilizing the ProteinChip®Array technology, will develop through the implementation of novel biomarkers and multimarker patterns for detecting disease, determining patient prognosis, monitoring drug effects such as efficacy or toxicity, and for defining treatment options. These biomarkers may also serve as novel protein drug candidates or protein drug targets. In addition, the technology can be used for discovering small molecule drugs or for defining their mode of action utilizing protein-based assays. In this review, we describe the following applications of the ProteinChip Array technology: (1) discovery and identification of novel inhibitors of HIV-1 replication, (2) serum and tissue proteome analysis for the discovery and development of novel multimarker clinical assays for prostate, breast, ovarian, and other cancers, and (3) biomarker and drug discovery applications for neurological disorders.

Sign in / Sign up

Export Citation Format

Share Document